Table 2.
PD Group | Pathways | MEs | Inflammatory biomarkers | Proteins | P value | Correlation | From |
---|---|---|---|---|---|---|---|
Actinobacteria phylum | L.histidine degradation I | LDLGITGPEGHVLSRPEEVEAEAV | MONO | DPYSL2 | 9.36E-05 | 0.452806 | Homo sapiens |
CGRPRAVYRKFGLCR | NEUT.1, WBC | RPSZ | 0.020310 | 0.278889 | Mycobacterium leprae | ||
AGGVAVIKAGAATEVELKERKH | MONO | RML65 | 0.010781 | 0.305162 | Mycobacterium tuberculosis | ||
ADMLVRAWVRSYGVRATISN | MONO.1, NEUT.1, WBC | RMLB | 0.035289 | 0.253884 | |||
L.proline biosynthesis II from arginine | LDLGITGPEGHVLSRPEEVEAEAV | MONO | DPYSL2 | 0.00025 | 0.427394 | Homo sapiens | |
NVDRTIRSVKRHMGSDWSIE | NEUT.1, WBC | DNAK | 0.000259 | 0.426357 | Mycobacterium leprae | ||
AGGVAVIKAGAATEVELKERKH | MONO | RML65 | 2.69E-08 | 0.609702 | Mycobacterium tuberculosis | ||
CGRPRAVYRKFGLCR | NEUT.1, WBC | RPSZ | 2.33E-07 | 0.575328 | |||
AGGVAVIKAGAATEVELKERKH | MONO | RML65 | 2.69E-08 | 0.609702 | |||
CGRPRAVYRKFGLCR | NEUT.1, WBC | RPSZ | 2.33E-07 | 0.575328 | |||
ADMLVRAWVRSYGVRATISN | MONO.1, NEUT.1, WBC | RMLB | 8.21E-07 | 0.553281 | |||
TEVELKERKHRIEDAVRNAK | NEUT.1, WBC | RML65 | 4.60E-05 | 0.470052 | |||
DAMRWFLMASPILRGGNLIV | NEUT.1, WBC | ILES | 0.000266 | 0.425705 | |||
HSDDFQIILVDTPGLHRPRT | NEUT.1 | ERA | 0.000819 | 0.393644 | |||
ERTRDRVRVDIHTARPGIVI | NEUT.1, WBC | RPSC | 0.001324 | 0.378935 | |||
RYTTIQNWSNNVYNL | NEUT.1, WBC | RV1461 | 0.005517 | 0.330683 | |||
ADPVKVTRSALQNAASIAGL | NEUT.1, WBC | GROEL2 | 0.009855 | 0.30871 | |||
Firmicutes phylum | Isopropanol biosynthesis | AGGVAVIKAGAATEVELKERKH | MONO | RML65 | 0.00453 | 0.337799 | Mycobacterium tuberculosis |
Pyruvate fermentation to propanoate I | LDLGITGPEGHVLSRPEEVEAEAV | MONO | DPYSL2 | 4.50E-05 | 0.265658 | Homo sapiens | |
ADMLVRAWVRSYGVRATISN | MONO.1, NEUT.1, WBC | RMLB | 5.42E-06 | 0.257598 | Mycobacterium tuberculosis |